Kyowa Kirin, Inc.- U.S. · 6 days ago
Oncology Regional Business Director - Great Lakes
Chicago, IL
Full-time
Onsite
Mid, Senior Level
$175K/yr - $200K/yr
2+ years expKyowa Kirin is a fast-growing global specialty pharmaceutical company focused on delivering novel medicines in critical disease areas. They are seeking an Oncology Regional Business Director to lead a regional team of Oncology Account Managers, develop and execute strategic sales plans, and drive performance to meet sales goals.
Pharmaceuticals
Responsibilities
Develop and execute a strategic Regional Sales Plan that is focused on centers of excellence, key oncology accounts & community oncology accounts to support key business drivers while supporting National Brand and Corporate Strategies
Provide strong, clear and compliant direction for the achievement of sales goals within the region using marketing plans and pull through managed markets strategies
Recruit, hire, train retain, develop and lead diverse high performing Oncology Account Managers to their full potential
Manage regional budget and allocate resources as appropriate
Monitor external trends and competitive market and share findings with the National Sales Director
Develop quarterly/annual pull-through plans and align quarterly sales efforts to meet these annual objectives
Fully understand and train region on IC Plan components and how to achieve goals set
Develop and maintain relationships with outside partners such as Institutions, Clinics and Networks to maximize sales results
Establish relationships with key Thought Leaders
Manage all areas of the sales teams performance including selling skills, administrative duties and career progression
Work on regional and national projects as assigned by the National Sales Director
Qualification
Required
Bachelor's degree required
2 to 8 years of prior Sales Management Experience in Hospitals or Account Sales
Experience in working with a buy and bill product
Knowledge of and relationships with Key Oncology Institutions and Clinics
Outstanding interpersonal & communication skills, including building strong working relationships, and managing and resolving conflict
Results oriented / Team oriented
Ability to travel up to 60% including overnight travel
Proven track record of success
Current knowledge of all relevant industry, legal and regulatory compliance guidelines
Commitment to the highest ethical, legal, regulatory and scientific standards
Must possess a valid driver's license
Proficient in MS Office Suite and Veeva is a must
Excellent organizational/communication skills, initiative, and ambition to succeed are all essential
Must possess a valid driver's license
Current knowledge of all relevant industry, legal and regulatory compliance guidelines
Commitment to the highest ethical, legal, regulatory and scientific standards
Preferred
Strongly prefer experience in oncology and or rare disease
Benefits
Medical, Dental & Vision Insurance, Basic and Voluntary Life and AD&D Insurance, Short- and Long-Term Disability Insurance, Flexible Spending Accounts, and Health Savings Account, Business Travel Insurance, Employee Assistance Programs
Pet Insurance
Retirement Savings 401k with company match and annual discretionary profit sharing
Well-Being and Work-Life Programs Including Gympass, Nutrition Counseling, , Volunteer Time Off, Flexible Work Arrangements, Parental Leave, Adoption Assistance, and TouchCare Insurance & Billing Support
Generous Paid Time Off, Sick Time, & Paid Holidays
Perks and Discounts with Tickets at Work and LifeMart
Reward & Recognition Programs
Career Development and Training
Company
Kyowa Kirin, Inc.- U.S.
Kyowa Kirin is a global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines.
501-1000 employees
Funding
Current Stage
Late StageLeadership Team
Ana Bastiani-Posner, MBA
Executive Vice President & Chief Financial Officer
Tara D'Orsi
Executive Vice President, Chief Compliance Officer and General Counsel at Kyowa Kirin North America
Recent News
Business Journals
2024-03-08
2024-03-03
Company data provided by crunchbase